Jessica Amir
Market Strategist
Summary: Watch our three minute video covering five stocks to watch this week. In no particular order stocks to watch include Dexcom which has become the best-performing stock in the S&P500 this month after announcing its newest glucose wearable device is available globally. Marathon Oil is another to watch which has been rallying after OPEC+ production cuts were announced. Plus what to watch when it comes to JPMorganChase’s results. And why to also keep Rivian and Fortescue Metals on your radar
Here are five stocks to perhaps watch in no particular order
Dexcom is so far the best performing stock in the S&P500 this month up 24% after announcing its newest glucose wearable device, Dexcom G7 is available globally, to those with diabetes aged 2 years and over. The wearable device is now selling in the UK, Ireland, Germany, Austria, and Hong Kong, with launches to take place soon in New Zealand and South Africa.
Marathon Oil (MRO)
Marathon Oil is also one of the best performers in the S&P500 so far this month, up 20%. Marathon Oil along with many oil and gas producers have been rallying this month following the Oil price (West Texas Intermediate) moving up 16% in 11 days. It comes as OPEC+ agreed to reduce oil output by 2 million barrels a day from November. So the market is once again dealing with supply fears in the oil market.
To find out more head to Saxo. Type in the Stock you want. And click on the Overview page for fundamental analysis.
-
For a global look at markets – tune into our Podcast.
2024: The wasted year
Markets are driven by election optimism, overshadowing growing debt and liquidity concerns. The 2024 elections loom large, but economic fundamentals and debt issues warrant cautious investment.
As US economic slowdown hints at a shift away from exceptionalism, USD faces downside with looming Fed cuts. AUD and NZD set to outperform as their rate cuts lag. JPY gains on carry unwind bets and BOJ pivot.
Amid AI and obesity drug excitement, equities see varied prospects: neutral on overvalued US stocks, negative on Japan due to JPY risks, positive on Europe. European defence stocks gain appeal.
With the economic slowdown, quality assets will gain favour, especially sovereign bonds up to 5 years. Central banks' potential rate cuts in Q2 suggest extending duration, despite policy and inflation concerns.
Commodities poised for rebound. The "Year of the Metal" boosts gold and silver, copper awaits rate cuts. Grains may recover, natural gas stabilises. Gold targets $2,300-$2,500/oz, copper's breakout could signal growth.
Markets are driven by election optimism, overshadowing growing debt and liquidity concerns. The 2024 elections loom large, but economic fundamentals and debt issues warrant cautious investment.
As US economic slowdown hints at a shift away from exceptionalism, USD faces downside with looming Fed cuts. AUD and NZD set to outperform as their rate cuts lag. JPY gains on carry unwind bets and BOJ pivot.
Amid AI and obesity drug excitement, equities see varied prospects: neutral on overvalued US stocks, negative on Japan due to JPY risks, positive on Europe. European defence stocks gain appeal.
With the economic slowdown, quality assets will gain favour, especially sovereign bonds up to 5 years. Central banks' potential rate cuts in Q2 suggest extending duration, despite policy and inflation concerns.
Commodities poised for rebound. The "Year of the Metal" boosts gold and silver, copper awaits rate cuts. Grains may recover, natural gas stabilises. Gold targets $2,300-$2,500/oz, copper's breakout could signal growth.